FDA Inspection
Reproductive Sciences Medical Center, Inc.Reproductive Sciences Medical Center, Inc. – FDA Inspection, Apr 8, 2026
Record Details
This FDA Inspection record concerns Reproductive Sciences Medical Center, Inc., with an inspection on April 8, 2026, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 0f1931a5-2da1-4243-8266-8348bbe9f69f
Inspection Facts
- Inspection number
- 1311486
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reproductive Sciences Medical Center, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 22, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 27, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 20, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 10, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Sciences Medical Center, Inc.
- FDA Inspection 1209585 - 2023-06-22
- FDA Inspection 1028550 - 2017-09-27
- FDA Inspection 922804 - 2015-03-20
- FDA Inspection 728860 - 2011-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.